Living network meta-analysis to compare nemolizumab against other available targeted systemic treatments for atopic dermatitis is a research paper published in British Journal of Dermatology (2025). On theSindex it has a DataRank of 0. It has been cited 14 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Canadian Institutes of Health Research
Grant: CIHR PJT 197879
National Institute for Health Research
Grant: CDF-2014-07-037
Medical Research Council Clinician Scientist Fellowship
Grant: MR/Z504026/1
Eczema Society of Canada
Academic Health Sciences Centres of Ontario
Innovation Fund
FWCI
15.62
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals